An open-label study to evaluate the safety and tolerability of inhaled Teicoplanin in the treatment of Staphylococcus aureus (including mrsa) infections in CYSTIC FIBROSIS PATIENTS - study to evaluate the safety of inhaled Teicoplanin in the treatment of Stafilococco infections

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2023
This article has no abstract
Epistemonikos ID: 040c333691b962a60d5315452d58206411787ff1
First added on: Apr 17, 2025